Prosecution Insights
Last updated: May 29, 2026
Application No. 18/337,282

SYSTEM AND METHOD FOR IMPLANTABLE MEDICAL DEVICE REMOTE PROGRAMMING

Non-Final OA §102§112
Filed
Jun 19, 2023
Priority
Jun 27, 2022 — provisional 63/367,064 +1 more
Examiner
WU, TONG E
Art Unit
3796
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Pacesetter Inc.
OA Round
1 (Non-Final)
70%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
86%
With Interview

Examiner Intelligence

Grants 70% — above average
70%
Career Allowance Rate
451 granted / 645 resolved
At TC average
Strong +16% interview lift
Without
With
+16.4%
Interview Lift
resolved cases with interview
Typical timeline
2y 11m
Avg Prosecution
21 currently pending
Career history
678
Total Applications
across all art units

Statute-Specific Performance

§101
0.5%
-39.5% vs TC avg
§103
58.1%
+18.1% vs TC avg
§102
5.3%
-34.7% vs TC avg
§112
9.4%
-30.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 645 resolved cases

Office Action

§102 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Group I, claims 1-7, in the reply filed on 11/3/25 is acknowledged. Claims 8-20 withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 11/3/25. Claim Objections Claims objected to because of the following informalities: Claim 1, line 2: Should be clinician “programming" device. Claim 4, line 6: Should be remote “programming” profile. Claim 5: Should be remote “programming” profile. Claim 7: Should be remote “programming” profile. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-7 rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1, lines 8-9: “the updated program instructions” lacks proper antecedent in the claims. For sake of examination, this is interpreted to be any program instructions. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Moffitt (US 2017/0157410). PNG media_image1.png 309 415 media_image1.png Greyscale Regarding claim 1, Moffitt discloses the same invention as claimed (Figure 24 shown above for example), including a medical device assembly comprising: a clinician programing device configured to communicate with an implanted medical device of a patient (Figure 1); the clinician programming device including one or more processors configured to: communicate program instructions to a remote programming engine (Figure 24; Paragraphs 114-115: physician device 910 communicates with remote intermediary 920), the remote programming engine comprising one or more processors configured to: simulate operation of the implanted medical device based on program instructions (Paragraph 117: analyzer simulates or emulates operation of an uploaded therapy program); and communicate updated program instructions to the implanted medical device based on the operation simulated (Paragraphs 117-119: e.g. design rules may be applied to the uploaded therapy programs; Paragraphs 120-121: user downloads any therapy program to pulse generator). To expedite allowance, Examiner suggests reciting the clinician programming device configured to communicate “initial” program instructions and the remote engine configured to simulate operation based on the “initial” program instructions, or similar language, to tie together the updated program instructions back to the simulation and initial program instructions. This would differentiate from Moffitt since there is no linkage between the separate uploading and downloading of therapy programs. Allowable Subject Matter Claims 2-7 would be allowable if rewritten to overcome the rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action and to include all of the limitations of the base claim and any intervening claims. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Abdeen (US 2020/0372996) shows a trainer device which emulates an IPG. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Eugene T Wu whose telephone number is (571)270-5053. The examiner can normally be reached M-F 8am-5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Carl Layno can be reached at 571-272-4949. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Eugene T Wu/Primary Examiner, Art Unit 3796
Read full office action

Prosecution Timeline

Jun 19, 2023
Application Filed
Nov 15, 2025
Non-Final Rejection (signed) — §102, §112
Jan 06, 2026
Non-Final Rejection mailed — §102, §112
Mar 31, 2026
Examiner Interview Summary
Mar 31, 2026
Response Filed
Mar 31, 2026
Applicant Interview (Telephonic)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12635914
PERSPIRATION AMOUNT MEASURING DEVICE AND PERSPIRATION AMOUNT MEASURING SYSTEM
2y 6m to grant Granted May 26, 2026
Patent 12629525
SYSTEM AND METHOD FOR CONTROLLING NEUROSTIMULATION ACCORDING TO USER ACTIVITY AND AUTOMATED RESCHEDULING OF STIMULATION PROGRAMS
3y 1m to grant Granted May 19, 2026
Patent 12629510
Apparatus For Applying Electrode Array To User, And Systems And Methods Comprising Same
2y 5m to grant Granted May 19, 2026
Patent 12589243
OCULAR DEVICES AND CONTROLLER INTERFACES FOR OCULAR THERAPY
2y 5m to grant Granted Mar 31, 2026
Patent 12558535
ADAPTIVE DEEP BRAIN STIMULATION USING MOVEMENT DESYNCHRONIZATION
2y 4m to grant Granted Feb 24, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
70%
Grant Probability
86%
With Interview (+16.4%)
2y 11m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 645 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month